Insulet (PODD) Change in Accured Expenses (2010 - 2026)

Insulet (PODD) posted Change in Accured Expenses of -$69.3 million for Q1 2026, down 142.96% on a QoQ basis from $161.3 million in Q4 2025, and down 42.59% year-over-year from -$120.7 million in Q1 2025.

Insulet (PODD) Change in Accured Expenses (2010 - 2026) Analysis & Trends

Insulet's Change in Accured Expenses history runs 17 years deep, the most recent figure standing at -$69.3 million for Q1 2026.

  • Quarterly Change in Accured Expenses fell 42.59% year-over-year to -$69.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $140.5 million (up 2281.36% YoY) and the FY2025 annual result came in at $161.2 million, up 2140.51% from the prior year.
  • Change in Accured Expenses was -$69.3 million for Q1 2026 at Insulet, down from $161.3 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $161.3 million in Q4 2025 and bottomed at -$69.3 million in Q1 2026.
  • A 5-year average of $12.6 million and a median of -$4.2 million in 2023 frame the typical range for Change in Accured Expenses.
  • Annual changes were most pronounced in 2022 — Change in Accured Expenses slumped 12033.33% — and 2025, when it jumped 1954.02%.
  • Insulet's Change in Accured Expenses stood at $132.1 million in 2022, then plunged by 103.18% to -$4.2 million in 2023, then plunged by 107.14% to -$8.7 million in 2024, then soared by 1954.02% to $161.3 million in 2025, then tumbled by 142.96% to -$69.3 million in 2026.
  • Business Quant data shows PODD's Change in Accured Expenses at -$69.3 million in Q1 2026, $161.3 million in Q4 2025, and $900000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn -
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn -654.00 Mn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn 123.00 Mn
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn -512.00 Mn
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn -347.10 Mn
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn 145.10 Mn
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn -250.00 Mn
8 Smith & Nephew 26.99 Bn 26.41 Bn - -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn 21.07 Mn
10 Insulet 11.52 Bn 11.04 Bn 529.10 Mn -69.30 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -69.30 Mn
Mar 31, 2026 -69.30 Mn
Dec 31, 2025 161.30 Mn
Dec 31, 2025 161.30 Mn
Sep 30, 2025 900,000.00
Sep 30, 2025 900,000.00
Jun 30, 2025 47.60 Mn
Jun 30, 2025 47.60 Mn
Mar 31, 2025 -48.60 Mn
Mar 31, 2025 -48.60 Mn
Dec 31, 2024 -8.70 Mn
Dec 31, 2024 -8.70 Mn
Sep 30, 2024 -7.40 Mn
Sep 30, 2024 -7.40 Mn
Jun 30, 2024 70.60 Mn
Jun 30, 2024 70.60 Mn
Mar 31, 2024 -62.40 Mn
Mar 31, 2024 -62.40 Mn
Dec 31, 2023 -4.20 Mn
Dec 31, 2023 -4.20 Mn